FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000795392> ?p ?o ?g. }

• W2000795392 endingPage "1411" @default.
• W2000795392 startingPage "1400" @default.
• W2000795392 abstract "Morbidity and mortality from acute coronary artery occlusion may be reduced if local myocardial adenosine concentration is augmented because 1) coronary collateral blood flow during ischemia increases with adenosine infusion, and 2) granulocytes that accumulate in the microcirculation during ischemia are, to a large extent, inhibited by adenosine from generating superoxide anion free radicals, from adhering to vascular endothelium, and from damaging endothelial cells in culture. Using a cultured lymphoblast model system, we found that 5-amino-4-imidazole carboxamide (AICA) riboside enhanced adenosine accumulation during ATP catabolism. Therefore, AICA riboside pretreatment was used in canine myocardium to selectively increase adenosine concentration in the ischemic area during 1 hour of ischemia. At 5 minutes of ischemia, endocardial flow to ischemic myocardium in saline-treated and AICA riboside-treated dogs was 0.06 +/- 0.03 and 0.34 +/- 0.11 ml/min/g, respectively (p less than 0.01); flow to nonischemic myocardium was not affected. Ventricular tachycardia and premature ventricular depolarizations were significantly attenuated in the AICA riboside-treated dogs. Blood pressure and heart rate were not affected by AICA riboside. In venous blood from ischemic tissue, adenosine increased from undetectable levels (less than 0.01 microM) to 0.22 +/- 0.08 microM in saline and 1.79 +/- 0.06 microM in AICA riboside-treated dogs, respectively (p less than 0.001). Coronary vein inosine concentrations were greater in saline than in AICA riboside-treated dogs. In separate in vitro studies, AICA riboside did not alter the removal rate of adenosine from canine blood. Indium-labeled granulocyte accumulation was significantly less in ischemic myocardium in AICA riboside-treated compared with saline-treated dogs. In addition, adenosine, but not AICA riboside, inhibited in vitro canine granulocyte superoxide production. We conclude that AICA riboside given before myocardial ischemia augments adenosine concentration, decreases arrhythmias, decreases granulocyte accumulation, and improves collateral flow to ischemic myocardium. One of the beneficial mechanisms could be an increased production of adenosine rather than inosine from ATP catabolism that causes vasodilation and inhibition of granulocytes. We propose a new hypothesis regarding regulation of the inflammatory reaction to ischemia in the microcirculation. Adenosine, in addition to its vasodilator action, is an anti-injury autacoid that links ATP catabolism to inhibition of granulocyte adherence, microvascular obstruction, and superoxide anion formation." @default.
• W2000795392 created "2016-06-24" @default.
• W2000795392 creator A5049533029 @default.
• W2000795392 creator A5050252616 @default.
• W2000795392 creator A5055382953 @default.
• W2000795392 creator A5058108856 @default.
• W2000795392 creator A5063298929 @default.
• W2000795392 creator A5078163062 @default.
• W2000795392 creator A5080849439 @default.
• W2000795392 date "1989-11-01" @default.
• W2000795392 modified "2023-10-18" @default.
• W2000795392 title "Increased adenosine concentration in blood from ischemic myocardium by AICA riboside. Effects on flow, granulocytes, and injury." @default.
• W2000795392 cites W1228007247 @default.
• W2000795392 cites W1525482898 @default.
• W2000795392 cites W1530070374 @default.
• W2000795392 cites W1584816909 @default.
• W2000795392 cites W1966766322 @default.
• W2000795392 cites W1978042597 @default.
• W2000795392 cites W1987594516 @default.
• W2000795392 cites W1997502768 @default.
• W2000795392 cites W2004107412 @default.
• W2000795392 cites W2023122744 @default.
• W2000795392 cites W2058656681 @default.
• W2000795392 cites W2067075110 @default.
• W2000795392 cites W2072782647 @default.
• W2000795392 cites W2093518775 @default.
• W2000795392 cites W2097744068 @default.
• W2000795392 cites W2103924942 @default.
• W2000795392 cites W2115654053 @default.
• W2000795392 cites W2117966002 @default.
• W2000795392 cites W2122689055 @default.
• W2000795392 cites W2259392365 @default.
• W2000795392 cites W2295031394 @default.
• W2000795392 cites W29771769 @default.
• W2000795392 cites W87082738 @default.
• W2000795392 doi "https://doi.org/10.1161/01.cir.80.5.1400" @default.
• W2000795392 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2553298" @default.
• W2000795392 hasPublicationYear "1989" @default.
• W2000795392 type Work @default.
• W2000795392 sameAs 2000795392 @default.
• W2000795392 citedByCount "191" @default.
• W2000795392 countsByYear W20007953922012 @default.
• W2000795392 countsByYear W20007953922013 @default.
• W2000795392 countsByYear W20007953922014 @default.
• W2000795392 countsByYear W20007953922015 @default.
• W2000795392 countsByYear W20007953922016 @default.
• W2000795392 countsByYear W20007953922018 @default.
• W2000795392 countsByYear W20007953922019 @default.
• W2000795392 countsByYear W20007953922020 @default.
• W2000795392 countsByYear W20007953922021 @default.
• W2000795392 countsByYear W20007953922022 @default.
• W2000795392 countsByYear W20007953922023 @default.
• W2000795392 crossrefType "journal-article" @default.
• W2000795392 hasAuthorship W2000795392A5049533029 @default.
• W2000795392 hasAuthorship W2000795392A5050252616 @default.
• W2000795392 hasAuthorship W2000795392A5055382953 @default.
• W2000795392 hasAuthorship W2000795392A5058108856 @default.
• W2000795392 hasAuthorship W2000795392A5063298929 @default.
• W2000795392 hasAuthorship W2000795392A5078163062 @default.
• W2000795392 hasAuthorship W2000795392A5080849439 @default.
• W2000795392 hasConcept C126322002 @default.
• W2000795392 hasConcept C158846371 @default.
• W2000795392 hasConcept C164705383 @default.
• W2000795392 hasConcept C2776157398 @default.
• W2000795392 hasConcept C2776328115 @default.
• W2000795392 hasConcept C2776991684 @default.
• W2000795392 hasConcept C2777610669 @default.
• W2000795392 hasConcept C42219234 @default.
• W2000795392 hasConcept C541997718 @default.
• W2000795392 hasConcept C55493867 @default.
• W2000795392 hasConcept C71924100 @default.
• W2000795392 hasConcept C86803240 @default.
• W2000795392 hasConceptScore W2000795392C126322002 @default.
• W2000795392 hasConceptScore W2000795392C158846371 @default.
• W2000795392 hasConceptScore W2000795392C164705383 @default.
• W2000795392 hasConceptScore W2000795392C2776157398 @default.
• W2000795392 hasConceptScore W2000795392C2776328115 @default.
• W2000795392 hasConceptScore W2000795392C2776991684 @default.
• W2000795392 hasConceptScore W2000795392C2777610669 @default.
• W2000795392 hasConceptScore W2000795392C42219234 @default.
• W2000795392 hasConceptScore W2000795392C541997718 @default.
• W2000795392 hasConceptScore W2000795392C55493867 @default.
• W2000795392 hasConceptScore W2000795392C71924100 @default.
• W2000795392 hasConceptScore W2000795392C86803240 @default.
• W2000795392 hasIssue "5" @default.
• W2000795392 hasLocation W20007953921 @default.
• W2000795392 hasLocation W20007953922 @default.
• W2000795392 hasOpenAccess W2000795392 @default.
• W2000795392 hasPrimaryLocation W20007953921 @default.
• W2000795392 hasRelatedWork W1982325051 @default.
• W2000795392 hasRelatedWork W1986466549 @default.
• W2000795392 hasRelatedWork W2000795392 @default.
• W2000795392 hasRelatedWork W2039208819 @default.
• W2000795392 hasRelatedWork W2107078721 @default.
• W2000795392 hasRelatedWork W2122873971 @default.
• W2000795392 hasRelatedWork W2415246214 @default.
• W2000795392 hasRelatedWork W2436569602 @default.
• W2000795392 hasRelatedWork W2992604246 @default.

• next